Growth Metrics

Opus Genetics (IRD) Enterprise Value Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Opus Genetics 357.99 Mn 298.03 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -15.41%
Dec 31, 2025 -1.85%
Sep 30, 2025 -30.20%
Jun 30, 2025 -23.66%
Mar 31, 2025 -29.20%
Dec 31, 2024 -7.00%
Sep 30, 2024 -17.38%
Jun 30, 2024 -19.56%
Mar 31, 2024 -64.49%
Dec 31, 2023 -45.50%
Sep 30, 2023 -73.79%
Jun 30, 2023 -63.19%
Mar 31, 2023 -52.51%
Dec 31, 2022 -111.15%
Sep 30, 2022 -0.10%
Jun 30, 2022 -1.79%
Mar 31, 2022 -2.47%
Dec 31, 2021 -18.90%
Sep 30, 2021 -21.67%
Jun 30, 2021 -13.12%
Mar 31, 2021 20.62%
Dec 31, 2020 15.14%
Sep 30, 2020 29.65%
Jun 30, 2020 29.94%
Mar 31, 2020 15.92%
Dec 31, 2019 39.34%
Sep 30, 2019 13.92%
Jun 30, 2019 5.71%
Mar 31, 2019 9.70%
Dec 31, 2018 14.35%
Sep 30, 2018 16.34%
Jun 30, 2018 13.63%
Mar 31, 2018 10.34%
Dec 31, 2017 6.38%
Sep 30, 2017 13.29%
Jun 30, 2017 11.17%
Mar 31, 2017 22.77%
Dec 31, 2016 -2.64%
Sep 30, 2016 -13.36%
Jun 30, 2016 -24.39%
Mar 31, 2016 -26.22%
Dec 31, 2015 -19.94%
Sep 30, 2015 -42.09%
Jun 30, 2015 -44.66%
Mar 31, 2015 -42.99%
Dec 31, 2014 -40.41%
Sep 30, 2014 -32.88%
Jun 30, 2014 -28.33%
Mar 31, 2014 -25.11%
Dec 31, 2013 -8.30%
Sep 30, 2013 1.84%
Jun 30, 2013 17.29%